Get started
Mind Medicine (MindMed) Inc.Mind Medicine (MindMed) Inc.Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

MNMD trade ideas

MNMD LONGBreakout, CHoCH, volume supporting the move, 20.82 target, march Opex expiration. nothing big, I like the setup. why are we running tho?? The confirmation of Robert F. Kennedy Jr. as the head of the U.S. Department of Health and Human Services could have a positive impact on biotech stocks, particularly in the psychedelic space. RFK Jr.'s support for mental health treatments using psychedelics like those being developed by Mind Medicine (MNMD) aligns with a potential shift in policy towards chronic disease prevention and alternative therapies. Analysts believe this could boost biotech companies focused on psychedelics, such as MNMD, which saw a slight uptick in stock following his confirmation.
NASDAQ:MNMDLong
by SPYDERMARKET
Keep a close eye on $MNMDMind Medicine (MindMed) Inc. ( NASDAQ:MNMD ): Technical and Fundamental Analysis As of February 3, 2025, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is trading at $7.26, an increase of $0.47 (approximately 6.92%) from the previous close. Mind Medicine Inc (MNMD) is an equity in the U.S. market. The current price is $7.26, with a change of 0.47 (6.92%) from the previous close. The intraday high is $7.45, and the intraday low is $6.53. The latest trade time is Monday, February 3, 17:55:43 UTC. Technical Analysis Recent trading activity shows an intraday high of $7.45 and a low of $6.53, indicating increased volatility. Technical indicators, such as moving averages and oscillators, suggest mixed signals. However, there is a significant increase in trading volume, which often signals strong momentum. Additionally, breakout potential is huge, with the possibility of a major price surge if key resistance levels are broken. According to TradingView, there is a neutral to slightly positive trend, with some indicators pointing to a potential upward move. (tradingview.com) Fundamental Analysis Mind Medicine focuses on developing psychedelic-based medicines for mental health treatments. The company has recently reported strong news, including positive results from clinical trials, which has attracted investor interest. Financial reports indicate increased spending on research and development, signaling an active pipeline of projects. However, like many biotech companies in the development phase, Mind Medicine currently does not generate significant revenue and relies on investor funding. Conclusion With increasing volume, strong news, and massive breakout potential, the chance of a major price surge is high. Keep a close eye on this stock and put MNMD on your radar! 🚀
NASDAQ:MNMD
by swingstocktraders
2
MNMD: The $36.55 Moonshot or Mirage? Boom or Bust Play!MNMD is displaying significant bullish momentum, recently establishing support at $4.50, where a key gap has formed. This level is now acting as a base for a potential continuation move, setting the stage for an explosive breakout. The stock is currently approaching the $12.22 weekly resistance level, a critical psychological and technical barrier. A decisive breakout above this level would confirm the bullish trend and attract momentum traders, likely fueling a strong rally. Why MNMD Could Push to $36.55: 🔹 Technical Momentum: Recent price action indicates strong accumulation, with increasing volume signaling growing investor interest. The stock has consistently made higher lows, reinforcing its bullish structure. 🔹 Gap Fill Potential: Historical price action suggests that once a stock begins filling a previous gap, there’s a high probability of it continuing toward the next resistance. If MNMD sustains above $12.22, the next major resistance zone is at $36.55, providing substantial upside. 🔹 Favorable Risk-to-Reward Setup: With a stop-loss at $2.45, this trade offers an exceptional risk-to-reward ratio, making it an attractive opportunity for traders willing to capitalize on momentum. 🔹 Psychological and Institutional Levels: Breakouts above key whole-number resistance levels often attract increased buying pressure from institutions and retail traders alike. A move past $12.22 could trigger stop orders and FOMO buying, accelerating the uptrend. Key Levels to Watch: ✅ Support: $4.50 (gap level), $2.45 (stop-loss) ✅ Breakout Trigger: $12.22 (weekly resistance) ✅ Target: $36.55 (major resistance) If MNMD maintains its momentum and breaks above $12.22 with volume, this could be the beginning of a major move toward $36.55, delivering high-upside potential with controlled risk. NASDAQ:MNMD
NASDAQ:MNMDLong
by The_Trading_Mechanic
MNMD - long - multi catalyst play - risky before 03/07/2024Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies. This is not a financial advice! 4 upcoming catalysts 03/07/2024 , 03/31/2024, 06/30/2024 and 12/31/2024 2024-03-01 MNMD Reiterates Buy 75.00 Maintains HC Wainwright & Co. Keep in mind the first catalyst is very close and we had already a nice run up. You can enter after the data release. We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work. Keep an eye on 9, 11, 13, 16, 20, 24 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains. SL under 4.5 TPs approx. 33 longterm Most info on the chart. Trade carefully!
NASDAQ:MNMDLong
by meitshels_smell_trades
7
MNMD - A Good Play or a Bad Trip?First, full disclosure - I took a position in MNMD on Monday of last week after it popped over the $5.00 barrier; it was a Trade Ideas (TI) "Trade of the Week" play, and I took it after careful tech analysis and considering the successes of the TI recommendations of the past. The stock took a dump on Tuesday, but I stayed in it because I thought the turndown was due to the anxiety in the overall market. So, looking at the chart, the price held the 8-day EMA very well. The momentum is favorable for an increase in price, but I think this stock is subject to market conditions. Several analysts (I think it is 7) have covered this company, and the target price looks to be intriguing. From Zolmax News : The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $23.50 I did tie up a good bit of capital in this trade, so I will be selling some soon, bit I will hold a good amount as a long-term swing trade or investment.
NASDAQ:MNMD
by stevepom
4
MNMD6M RSI is at a top. MFI is at 60, not yet exhausted. I think the RSI could hold at the top for a time on this timeframe. 1Y RSI is at a bottom. MFI is around 60, with a downward sloping trend. I think we could hold a low RSI for a time on this timeframe going towards lower lows. 5Y RSI is trending up, while it is correcting a bit. MFI looks like it is trending up, while correcting a bit. Conclusion: There is a gap around $2 that I believe we are going to fill. Around that could be a good entry point. For my educational purpose, not to be used as financial advice.
NASDAQ:MNMDShort
by Kyo026
MNMD Long based on Fundmntls, Lvls and MetaWorldCrypto indicatorHypothesis: pharmaceutical company price depressed due to conflict between management and investor, price artificially low due to FUD. Confluence on W1 charts: 1. Price near ATL and 2020 support levels (year of IPO), see Early 2020 Support, and 2020 Support Levels. 2. Advanced RSI in oversold band with three Regular Divergence -Bullish signals 3. Setups & Trends also showing same three Regular Divergence - Bullish signals (same signals as above) 4. StRSI <10% with K crossed up D Confluence on H1 chart 1. Price below Early 2020 and 2020 support levels and bouncing off Oct 2022 support. 2. Setup & Trend and Advanced RSI showing three Regular Divergence - Bull signals Position: Entered at $2.82 with SL at $2.70, TP1 at $3.75 Risk Management: RR 7.75, Portfolio Risk % 0.43%, SL% Loss 4.26%, TP1% Gain 32.98%
NASDAQ:MNMDLong
by metadimensional
MNMD Biotech Penny Stock SHORT SETUPNASDAQ:MNMD Yj This stock had a quick response to good earnings and it is now at resistance with the RSI swing indicator printing a Sell Signal. The MACD, a lagging indicator, shows the signal above the histogram without a K / D cross not yet started. I would like to take a short trade setting a stop loss above the resistance zone and targeting 10% to the POC line of the volume profile sitting above the support zone. Please comment and offer your opinion. 3
NASDAQ:MNMDShort
by AwesomeAvani
8
Mind Medicine Canada Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision. #debadipb #profitsolutions
M
by Sunstorminvest